Rr595em1Weij
Endonuclease-mediated Allele Detail
|
Symbol: |
Rr595em1Weij |
Name: |
regulatory region 595; endonuclease-mediated mutation 1, Wei Jiang |
MGI ID: |
MGI:7855055 |
Gene: |
Rr595 Location: unknown Genetic Position: Chr2, Syntenic
|
Alliance: |
Rr595em1Weij page
|
|
Strain of Origin: |
Not Applicable
|
|
Allele Type: |
|
Endonuclease-mediated (Humanized sequence, Modified regulatory region) |
Mutation: |
|
Single point mutation
|
|
|
Mutation details: A single nucleotide mutation (GRCm39:chr2:g.147882499A>G), in an intergenic region, was engineered using sgRNAs (equivalent to GCCCCCCCAGTTCCAAGTTTAGG and CACAGAGTCCGCCCCCCACTCGG) and an ssODN template with CRISPR/Cas9 technology. This mutation is the equivalent of human non-coding SNP rs6048205 (NC_000020.11:22578963:A>G), associated with higher fasting-glucose levels and impaired beta cell function. The mutation leads to higher Foxa2 expression levels in pancreatic progenitor cells.
(J:358609)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Rr595 Mutation: |
0 strains or lines available
|
|
Original: |
J:358609 Li Y, et al., A noncoding variant confers pancreatic differentiation defect and contributes to diabetes susceptibility by recruiting RXRA. Nat Commun. 2024 Nov 12;15(1):9771 |
All: |
1 reference(s) |
|